Direct and indirect costs of COPD and its comorbidities: Results from the German COSYCONET study
Authors:
- M.E. WackerMWM.E. Wacker
- J. HeinrichJ. Heinrich
- S. KarraschSKS. Karrasch
- A. PetersAPA. Peters
- 1 February 2016
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 111, 39-46
Abstract
No abstract availableKeywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (01GI0881)
- Deutsches Forschungszentrum für Gesundheit und Umwelt, Helmholtz Zentrum München (01ET0713)
This publication has 27 references indexed in Scilit:
- Comorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic ReviewPLOS ONE, 2015
- Economic Burden of COPD in the Presence of ComorbiditiesChest, 2015
- Excess Costs of Comorbidities in Chronic Obstructive Pulmonary Disease: A Systematic ReviewPLOS ONE, 2015
- Systematic Review of Humanistic and Economic Burden of Symptomatic Chronic Obstructive Pulmonary DiseasePharmacoEconomics, 2015
- Epidemiology and clinical impact of major comorbidities in patients with COPDInternational Journal of Chronic Obstructive Pulmonary Disease, 2014
- Impact of co-morbidities on self-rated health in self-reported COPD: An analysis of NHANES 2001–2008COPD: Journal of Chronic Obstructive Pulmonary Disease, 2013
- Comorbidities and Burden of COPD: A Population Based Case-Control StudyPLOS ONE, 2013
- Clusters of Comorbidities Based on Validated Objective Measurements and Systemic Inflammation in Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Determinants of elevated healthcare utilization in patients with COPDRespiratory Research, 2011
- Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQHealth and Quality of Life Outcomes, 2010